Early Atheroma-Derived Agonists of Peroxisome Proliferator-Activated Receptor-γ Trigger Intramedial Angiogenesis in a Smooth Muscle Cell-Dependent Manner

被引:40
|
作者
Ho-Tin-Noe, Benoit [1 ,2 ,3 ]
Le Dall, Julien [1 ,2 ,3 ]
Gomez, Delphine [1 ,2 ,3 ]
Louedec, Liliane [1 ,2 ,3 ]
Vranckx, Roger [1 ,2 ,3 ]
El-Bouchtaoui, Morad [4 ,5 ]
Legres, Luc [4 ]
Meilhac, Olivier [1 ,2 ,3 ]
Michel, Jean-Baptiste [1 ,2 ,3 ]
机构
[1] Univ Paris Diderot, INSERM, UMR698, Paris, France
[2] Hop Bichat Claude Bernard, AP HP, F-75877 Paris 18, France
[3] Univ Paris 07, Paris, France
[4] INSERM, U728, Pathol Lab, Paris, France
[5] Hop St Louis, AP HP, Serv Pathol, Paris, France
关键词
smooth muscle cells; angiogenesis; atherosclerosis; vascular endothelial growth factor; peroxisome proliferator-activated receptor; GROWTH-FACTOR EXPRESSION; HUMAN CAROTID ARTERIES; PPAR-GAMMA; IN-VIVO; ATHEROSCLEROTIC LESIONS; ENDOTHELIAL-CELLS; INTRAPLAQUE HEMORRHAGE; PLAQUE VULNERABILITY; OXIDIZED LDL; VASA VASORUM;
D O I
10.1161/CIRCRESAHA.110.235390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Neovascularization favors intraplaque hemorrhage and plaque rupture. Development of therapeutic strategies against atheromatous angiogenesis requires elucidation of its initiating factors. Objective: We investigated the contribution of smooth muscle cells (SMCs) and atheroma-derived lipids to the initiation of atheroma-associated neoangiogenesis. Methods and Results: Forty human aortic segments, each harvested from a different donor, were classified as healthy or as bearing early atheromatous lesions, including fatty streaks and fibrolipidic atheroma, according to their histological features. Immunostaining for blood vessels and vascular endothelial growth factor-A (VEGF-A), as well as measurement of VEGF-A protein and mRNA levels by ELISA and real-time PCR, revealed that angiogenesis and VEGF-A production were enhanced in the medial layer of atheromatous aortas. The intramedial vessel density and invasiveness and the production of VEGF-A by medial SMCs were indeed increased in atheromatous aortas compared with healthy aortas. Furthermore, intimal layers of atheromatous aortas were enriched in soluble lipid mediators capable of inducing a sustained increase in VEGF-A production by medial SMCs, turning these cells into potent inducers of angiogenesis when incorporated into mouse Matrigel implants. Both effects were inhibited by the peroxisome proliferator-activated receptor-gamma inhibitor GW9662 and mimicked by its agonist, rosiglitazone. Conclusions: We show that VEGF-A production is upregulated in medial SMCs of human atheromatous aortas and that peroxisome proliferator-activated receptor-gamma agonists derived from early intimal lesions are likely to contribute to this phenotypic change. Our findings suggest that medial SMCs are central organizers of an angiogenic response initiated by the subendothelial accumulation of atherogenic lipids. (Circ Res. 2011;109:1003-1014.)
引用
收藏
页码:1003 / U67
页数:24
相关论文
共 50 条
  • [1] The peroxisome proliferator-activated receptor-γ agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-α- dependent manner in vitro and in vivo in mice
    Orasanu, Gabriela
    Ziouzenkova, Ouliana
    Devchand, Pallavi R.
    Nehra, Vedika
    Hamdy, Osama
    Horton, Edward S.
    Plutzky, Jorge
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (10) : 869 - 881
  • [2] Peroxisome proliferator-activated receptor-γ (PPAR-γ) expression and vascular smooth muscle cell proliferation
    Lee, MK
    Min, KM
    Lee, MS
    Kim, KW
    DIABETES MELLITUS: RECENT ADVANCES FOR THE 21ST CENTURY, 2000, 1209 : 173 - 176
  • [3] Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-γ ligand therapy
    Bishop-Bailey, D
    Hla, T
    Warner, TD
    CIRCULATION RESEARCH, 2002, 91 (03) : 210 - 217
  • [4] Vascular Smooth Muscle Cell-Selective Peroxisome Proliferator-Activated Receptor-γ Deletion Leads to Hypotension
    Chang, Lin
    Villacorta, Luis
    Zhang, Jifeng
    Garcia-Barrio, Minerva T.
    Yang, Kun
    Hamblin, Milton
    Whitesall, Steven E.
    D'Alecy, Louis G.
    Chen, Y. Eugene
    CIRCULATION, 2009, 119 (16) : 2161 - 2169
  • [5] Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ deletion promotes abdominal aortic aneurysms
    Hamblin, Milton
    Chang, Lin
    Zhang, Hengmin
    Yang, Kun
    Zhang, Jifeng
    Chen, Y. Eugene
    JOURNAL OF VASCULAR SURGERY, 2010, 52 (04) : 984 - 993
  • [6] Significance of peroxisome proliferator-activated receptor-γ (PPAR-γ) expression in vascular smooth muscle cells
    Lee, MK
    Min, KM
    Oh, EY
    Kim, SH
    Kim, KW
    DIABETES, 1999, 48 : A130 - A130
  • [7] Peroxisome proliferator-activated receptor-γ agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells
    Yamakawa, K
    Hosoi, M
    Koyama, H
    Tanaka, S
    Fukumoto, S
    Morii, H
    Nishizawa, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 271 (03) : 571 - 574
  • [8] Peroxisome proliferator-activated receptor-γ agonists suppress adrenocortical tumor cell proliferation and induce differentiation
    Betz, MJ
    Shapiro, I
    Fassnacht, M
    Hahner, S
    Reincke, M
    Beuschlein, F
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07): : 3886 - 3896
  • [9] TROGLITAZONE INHIBITS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION IN A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARγ)-INDEPENDENT MANNER
    Alkoot, Hossam
    Hargreaves, Adam
    Dannoura, Abeer
    Pereira, Ines
    Giraldo-Ramirez, Alejandro
    Brooks, Gavin
    Bicknell, Katrina
    HEART, 2014, 100